Back in April we hosted an online conference for our community, Orbit 2021, and in listening to Henning Kuich, Dan Plischke, and Joren Retel from Bayer Pharmaceuticals, the community got a glimpse into how a team within Bayer Pharmaceuticals uses TypeDB to accelerate their drug discovery pipelines.
Objective
The team at Bayer fundamentally wanted to understand diseases better so that they can create better therapeutic interventions. A deeper understanding of diseases enables the identification and development of novel therapeutic interventions that have little to no side effects.